In addition, it has been reported that SEMA3B-AS1 is downregulated in hepatocellular carcinoma cells (HCC) and that its overexpression may inhibit the proliferation of HCC cells by upregulating PTEN via the downregulation of miR-718 [29]. This evidence concerns the gene SEMA3B and hepatocellular carcinoma.